watch
Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

Sector: Pharmaceutical Preparations Region: India


: | Bombay Stock Exchange: 500124 | New York Stock Exchange: RDY | Frankfurt Stock Exchange: RDDA


Similar to: Hutchison China MediTech Ltd., Transgene SA, Sareum Holdings Plc

Dr. Reddy's Laboratories Ltd. is a global pharmaceutical company that manufactures and markets pharmaceutical products. It operates through three business segments which include Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products. The Pharmaceutical Services & Active Ingredients segment consists of its Active Pharmaceutical Ingredients business and Custom Pharmaceutical Services business. It also includes contract research services and the manufacture and sale of active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Global Generics segment consists of finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). It includes the operations of the company's biologics business. The Proprietary Products segment involves the discovery of new chemical entities and differentiated formulations for subsequent commercialization and out-licensing. The company's differentiated formulations portfolio consists of new, synergistic combinations and technologies that improve safety and/or efficacy by modifying pharmacokinetics of existing medicines. It also involves the company's specialty pharmaceuticals business, which conducts sales and marketing operations for in-licensed and co-developed dermatology products. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Sanjay Shetgar, Dr. Reddy's Laboratories-full video

Dr. Reddy's Laboratories Ltd. video

Sanjay Shetgar, Dr. Reddy's Laboratories-full video

Executives

GV Prasad , Chairman and Chief Executive Officer
Prasad leads the core team which drives growth and performance at Dr. Reddy’s. He is the architect of the company’s successful Global Generics and API strategies, and has spearheaded Dr. Reddy’s foray into Biosimilars and Differentiated Formulations. His efforts have led the company to a leadership position in the Indian pharmaceutical sector and helped create a significant presence globally, while being recognized for scientific innovation, people practices, and corporate governance.

Prasad serves on the boards of the Indian School of Business, Institute of Life Sciences, Infotech Enterprises, and Acumen Fund. Causes which are closest to his heart include sustainable development and higher education. The premium Prasad places on sustainability thinking has helped Dr. Reddy’s embrace green technologies and processes, and thereby reduce the company’s ecological footprint.

A Chemical Engineer from the Illinois Institute of Technology in Chicago, Prasad additionally holds a Master’s degree in Industrial Administration from Purdue University, US.
Satish Reddy , Vice Chairman and Managing Director
Satish Reddy steers two of the company’s core businesses: Pharmaceutical Services & Active Ingredients (PSAI) and Global Generics businesses. He joined Dr. Reddy’s in 1993 as Executive Director and in 1997, went on to become the Managing Director of the company.

Satish serves as a National Council member of Confederation of Indian Industry (CII), as Chairman of CII National Committee on Drugs and Pharmaceuticals, and as an executive council member of the Indian Pharmaceutical Alliance (IPA). Earlier, he was also a member of the Drugs Technical Association Board (DTAB) of India, the highest policy making body under the Drugs and Cosmetics Act in India between 2005- 2011.

Satish received the 2009 Distinguished Alumnus Award from the School of Pharmacy and Pharmaceutical Sciences, Purdue University, U.S.A. He was identified as a “Young Global Leader for 2007” by the World Economic Forum, and was awarded the “IBLA - India Corporate Citizen of the Year" by CNBC in 2005 for his efforts in the area of Corporate Social Responsibility. At present, he is a trustee of Dr. Reddy’s Foundation (DRF), a not-for-profit organization that focuses on creating sustainable livelihood and providing education to under privileged youth.

Satish holds a degree in Chemical Engineering from Osmania University, India, and an M.S. in Medicinal Chemistry from Purdue University, USA.
Saumen Chakraborty, President, Chief Financial Officer and Global Head of IT&BPE;
Saumen Chakraborty is President and Chief Financial Officer of Dr. Reddy’s. He has over 28 years of experience in both strategic and operational aspects of management and has played a significant role in the evolution of Dr. Reddy's as a global pharmaceutical company from India. He is responsible for managing Dr. Reddy’s global finance functions including among others Accounts and Controlling, Taxation, Compliance, Secretarial, Investor Relations and Treasury. In addition, Saumen is also responsible for the IT & Business Process Excellence (BPE) functions at Dr. Reddy's.

Saumen joined Dr. Reddy’s in 2001 as Global Chief of Human Resources and took over additional responsibility of IT & BPE in 2004. He became the Chief Financial Officer in 2006 and then President – Corporate & Global Generics Operations in 2009. In 2010 he was appointed as President and Global Head of Quality, HR and IT and focused on the integration of people practices, processes and information across the organization. Having championed various world-class HR initiatives, Saumen’s efforts have helped transform Dr. Reddy’s into one of the most respected employers in India and also a ‘Great Place to Work’.

As the Chief Financial Officer, Saumen was the recipient of the ‘Best Performing CFO in the Healthcare Sector’ award for 2007 by CNBC TV-18. Some of the organization’s achievements while he was in this role include: the secondary ADS issue on NYSE, one of the fastest issue of bonus shares in India, active Treasury and M&A strategies for the organization, and revamping the Board reporting processes. Other key portfolios and initiatives Saumen has handled in his current and previous roles at CMC, C-DOT, Eicher, Tecumseh and Dr. Reddy’s include manufacturing, sourcing, customer service, TQM and IT.

At Dr. Reddy’s, Saumen has been the driving force behind numerous successful initiatives like the complete implementation of mySAP Business Suite, Theory of Constraints (TOC) based approach to product development, manufacturing, supply chain effectiveness, and achieving Execution Excellence through the simplification of end-to-end business processes, among others.

Saumen is a member of the National Leadership Committee of CII. He has been on the board of the AHRD and various joint ventures/subsidiaries of Dr. Reddy’s. He has been the University topper, Gold medalist in NCC as Best Cadet and captain of volleyball and football teams. His passion statement in life is to strive for excellence in everything with honesty, commitment, courage and character. Saumen is a Graduate in Physics from Visva-Bharati University and has a degree in Management from the Indian Institute of Management, Ahmedabad.

News & Analysis

You may also be interested in: